Over 93% of bariatric patients said they would undergo bariatric surgery again, compared with just over half of those who said they would take GLP-1 medications, 0.4% said they aren’t sure they would consider getting bariatric surgery again, no respondents said that they definitely would not consider it, whilst 6.2% said they might. In comparison, 51.4% of participants said they would use GLP-1s again, 34.7% said they might use them again and 13.9% said they would not use them again.
For the survey, 256 patients who had GLP-1 medications or bariatric surgery were surveyed and analysed based on a variety of categories. These categories included the amount of weight lost, and how happy patients were with the outcomes. The results were compiled to compare bariatric surgery patients with GLP-1 users.
Interestingly, is also worth noting the barrier to entry with bariatric procedures. While 12% of adults in the US have used GLP-1s, only 1% of eligible patients have received bariatric surgery.
Regarding weight loss, 57.1% of patients lost at least 20lbs by using GLP-1s, 42.9% of GLP-1 users reported losing less than 20lbs and nearly 50% of GLP-1 users said they didn’t lose 20 pounds or more. This is compared with 98.1% of bariatric surgery patients reported losing at least 20lbs, with only 1.9% of bariatric surgery patients reported weight loss under 20lbs.
The lowest amount reported lost by bariatric patients was 13lbs, the lowest weight loss reported by GLP-1 patients was 0 pounds, the highest amount of weight lost from bariatric surgery participants was 250lbs and 100lbs for GLP-1 users - highlighting the potential gap in efficiency between bariatric surgery and GLP-1 treatment.
Bariatric surgery patients reported an average weight loss of 101.2lbs, compared to an average of 24.9lbs reported by GLP-1 users. These averages are still slightly higher than their respective medians. Bariatric surgery shows more promise for providing weight loss.
To view the study, please click here
Comments